Assessment and monitoring of lung disease in patients with severe alpha 1 antitrypsin deficiency: a european delphi consensus of the EARCO group
These results provide expert opinions for the assessment and monitoring of patients with severe AATD, which could be used to provide updated recommendations and standardized treatment pathways for patients across Europe.
Authors
- Noel G. McElvaney (ORCID: https://orcid.org/0000-0002-0152-4370)
- Alice Margaret Turner (ORCID: https://orcid.org/0000-0002-5947-3254)
- Marc Miravitlles (ORCID: https://orcid.org/0000-0002-9850-9520)
- Timm Greulich (ORCID: https://orcid.org/0000-0002-2368-3014)
- Maria Sucena (ORCID: https://orcid.org/0000-0002-0115-7080)
- Jean‐François Mornex
- Marion Wencker
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Royal College of Surgeons in Ireland (IE)
- Inserm (FR)
- Beaumont Hospital (IE)
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- Hospices Civils de Lyon (FR)
- Vall d'Hebron Institut de Recerca (ES)
- Hospital de Santo António (PT)
- Vall d'Hebron Hospital Universitari (ES)
- German Center for Lung Research (DE)
- NIHR Surgical Reconstruction and Microbiology Research Centre (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- Respiratory Research
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1186/s12931-024-02929-5
- Citations
- 5
- Primary Topic
- Protease and Inhibitor Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 1.43
Funders
- AstraZeneca
- GlaxoSmithKline
- Fondazione IRCCS Policlinico San Matteo
- Univerzita Karlova v Praze
- CSL Behring
- Queen Elizabeth Hospital Birmingham Charity
- University College London
- Universität Heidelberg
- Gentofte Hospital
- Universitair Ziekenhuis Gent
- Università Campus Bio-Medico di Roma
- Universiteit Gent
- Università degli Studi di Pavia
- Universität des Saarlandes
- Universidad de Granada
- Tartu Ülikool
- Universitätsspital Zürich
- Grifols
- lékařská fakulta Univerzity Karlovy